What does Osage University Partners invest in?
Osage University Partners invests most often at Series A and Series B (65% of the rounds on record), in sectors such as Graduate, Environnement and Mental Health.

United States · Investor
Last cheque observed Aug 2026; 93 cheques on record.
Deploying nowNew fund $196M, Apr 2023VC firm
Follow Osage University Partners and see its new cheques in your feed.Start following
3 cheques in the last 12 months
Mostly Series A and Series B: 65% of its rounds
Sole investor in 3 rounds, median $5.8M
6 exits from the portfolio
Every round we can evidence, newest first93 appearances
3 rounds
1 round
2 rounds
16 rounds
9 rounds
9 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration6 named
We also hold 25 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
From their own portfolio page (on their website)
Investor PortalMemberhere
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed6 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Osage University Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Osage University Partners put money into.
Osage University Partners invests most often at Series A and Series B (65% of the rounds on record), in sectors such as Graduate, Environnement and Mental Health.
93 investments on record, 3 of them in the last 12 months. The most recent was in Aug 2026.
Its most recent investments on record: Quintessent (Series A, Aug 2026), Tessera Labs (Series A, May 2026) and Nocion Therapeutics (Series B, Jan 2026).
The median round it joins is $40M. It says it writes cheques of $5.0M to $20M.
Rarely, if at all: none of its 93 investments on record names it as the lead.
Most of the companies it backs are in the United States (97%).
Yes: it is actively investing, with 3 investments in the last 12 months.
Most often OrbiMed (11 rounds together), New Enterprise Associates (8 rounds together) and Canaan (6 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it